# Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

> **NCT00499395** · NA · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** radiofrequency ablation

## Key facts

- **NCT ID:** NCT00499395
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2012-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00499395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00499395, "Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00499395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*